- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07286877
Enhanced Ward Rounds and Communication for Pre-procedural Anxiety in GI Endoscopy Patients
Enhanced Ward-Round Frequency With Standardized Communication for Pre-procedural Anxiety in Hospitalized Patients Undergoing Therapeutic Gastrointestinal Endoscopy
This study tests a new way to help reduce anxiety in hospitalized patients waiting for therapeutic gastrointestinal (GI) endoscopy procedures, like EMR or ESD. Anxiety before these procedures is common and can make preparation harder, increase medication needs, and affect recovery.
We compare standard ward checks (twice a day) to enhanced checks (four times a day) with structured talks and simple relaxation exercises. The goal is to see if the enhanced approach lowers anxiety levels, measured by a standard scale called the Hamilton Anxiety Rating Scale (HAM-A), from baseline to 24 hours before the procedure.
Who can join? Adults (18+) scheduled for inpatient GI endoscopy with at least 2 days hospital stay and mild anxiety. Exclusions include emergencies or severe mental health issues.
The study is done in hospital wards, with groups assigned by ward periods to keep it real-world. Benefits may include less anxiety and better experience; risks are low as it's just more supportive talks. Participation is voluntary with informed consent. Results could improve hospital care routines.
Study Overview
Status
Conditions
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Qiangqiang Tian
- Phone Number: 15009460497
- Email: tianqq2023@lzu.edu.cn
Study Locations
-
-
Gansu
-
Lanzhou, Gansu, China, 730000
- The First Hospital of Lanzhou University
-
Contact:
- Qiangqiang Tian
- Phone Number: 86+15009460497
- Email: tianqq2023@lzu.edu.cn
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Age ≥18 years.
- Inpatients scheduled for therapeutic gastrointestinal endoscopy (e.g., ESD/EMR, therapeutic colonoscopy).
- Able to provide informed consent and complete required assessments.
Exclusion Criteria:
Emergency/immediate endoscopy required.
- Severe cognitive impairment or psychotic disorder affecting assessments. Isolation/single room preventing protocol implementation.
- Unable to complete the primary pre-procedure assessment within the 2-4 hour window.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Enhanced Ward Rounds (4/day) with Standardized Communication
In intervention wards/periods, the care team conducts four brief, structured ward-round contacts per day (morning 07:00-09:00, midday 11:00-13:00, afternoon 15:00-17:00, and bedtime 19:00-21:30), each lasting approximately 3-5 minutes.
Each contact uses a standardized communication script addressing patient concerns, provides concise procedure-related education, and includes a 2-3 minute relaxation/breathing exercise.
For patients undergoing lower GI procedures, a bowel preparation checklist is reviewed and an information card is issued/verified at each contact.
Delivery starts at enrollment and continues through 24-48 hours post-procedure or until discharge, whichever comes first.
Staff receive standardized training with competency assessment; fidelity is monitored via daily checklists with an adherence target of ≥85%.
All usual clinical care remains available at all times.
|
In intervention wards/periods, the care team conducts four brief, structured ward-round contacts per day (morning, noon, afternoon, and a bedtime contact not later than 21:30), each lasting approximately 3-5 minutes.
Each contact uses a standardized communication script that addresses patient concerns, provides concise procedure-related education, and includes a 2-3 minute relaxation/breathing exercise; for lower GI procedures, a bowel preparation checklist is reviewed and an information card is issued/verified.
Delivery starts at enrollment and continues through 24-48 hours post-procedure or until discharge, whichever comes first.
Staff receive standardized training; fidelity is monitored via daily checklists with an adherence target of ≥85%.
Usual clinical care remains available at all times.
Other Names:
|
|
Active Comparator: Usual Care Ward Rounds (2/day)
Routine ward rounds twice daily (morning 07:00-09:00 and afternoon 15:00-17:00) according to standard hospital practice, without additional structured rounds, standardized communication scripts, scheduled relaxation exercises, or structured bowel preparation checklists beyond usual patient education.
Applied from enrollment through 24-48 hours post-procedure or until discharge, whichever comes first.
Clinically necessary additional contacts are permitted and recorded as protocol deviations.
All other aspects of care follow standard institutional pathways.
|
Routine ward rounds twice daily (morning and afternoon) according to standard hospital practice, without additional rounds, the standardized communication script, relaxation exercise, or the structured bowel preparation checklist beyond usual education.
Applied from enrollment through 24-48 hours post-procedure or until discharge, whichever comes first.
Any clinically necessary deviations are permitted and recorded as protocol deviations; all other aspects of care follow standard pathways.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Hamilton Anxiety Rating Scale (HAM-A) Score
Time Frame: Baseline and 3 hours (±1 hours) before scheduled endoscopy procedure (assessed up to 14 days after enrollment)
|
The Hamilton Anxiety Rating Scale (HAM-A) is a clinician-administered instrument assessing anxiety severity.
Total score ranges from 0 to 56 points, with higher scores indicating worse anxiety.
Score interpretation: 0-7 = no anxiety, 8-16 = mild anxiety, 17-24 = mild-to-moderate anxiety, 25-30 = moderate-to-severe anxiety, >30 = severe anxiety.
Assessed by blinded research assistants using structured interview.
|
Baseline and 3 hours (±1 hours) before scheduled endoscopy procedure (assessed up to 14 days after enrollment)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Hospital Consumer Assessment of Healthcare Providers and Systems (HCAHPS) Overall Hospital Rating
Time Frame: At hospital discharge (assessed up to 21 days after enrollment)
|
HCAHPS Overall Hospital Rating measures patient satisfaction with hospital care on a scale of 0 to 10, where 0 = worst hospital possible and 10 = best hospital possible.
Higher scores indicate better patient satisfaction.
|
At hospital discharge (assessed up to 21 days after enrollment)
|
|
HCAHPS Communication with Nurses Composite Score
Time Frame: At hospital discharge (assessed up to 21 days after enrollment)
|
HCAHPS Communication with Nurses composite includes 3 items rated on a 4-point frequency scale (Never/Sometimes/Usually/Always).
Scores are converted to a 0-100 scale where higher scores indicate better nurse communication.
Items assess whether nurses treated patient with courtesy/respect, listened carefully, and explained things understandably.
|
At hospital discharge (assessed up to 21 days after enrollment)
|
|
HCAHPS Communication with Doctors Composite Score
Time Frame: At hospital discharge (assessed up to 21 days after enrollment)
|
HCAHPS Communication with Doctors composite includes 3 items rated on a 4-point frequency scale (Never/Sometimes/Usually/Always).
Scores are converted to a 0-100 scale where higher scores indicate better doctor communication.
Items assess whether doctors treated patient with courtesy/respect, listened carefully, and explained things understandably.
|
At hospital discharge (assessed up to 21 days after enrollment)
|
|
Pittsburgh Sleep Quality Index (PSQI) Global Score
Time Frame: Baseline, Day 2 post-enrollment, and 24 hours before procedure (assessed up to 14 days after enrollment)
|
The Pittsburgh Sleep Quality Index (PSQI) assesses sleep quality over the previous night.
Global score ranges from 0 to 21, with higher scores indicating worse sleep quality.
A global score >5 indicates poor sleep quality.
|
Baseline, Day 2 post-enrollment, and 24 hours before procedure (assessed up to 14 days after enrollment)
|
|
Procedural Pain/Discomfort Visual Analog Scale (VAS)
Time Frame: Within 30 minutes after endoscopy procedure completion
|
Visual Analog Scale (VAS) for procedural pain and discomfort ranges from 0 to 10, where 0 = no pain/discomfort and 10 = worst imaginable pain/discomfort.
Higher scores indicate worse pain/discomfort.
Assessed immediately post-procedure.
|
Within 30 minutes after endoscopy procedure completion
|
|
Total Sedation Medication Dose (Midazolam Equivalents)
Time Frame: During endoscopy procedure (assessed up to 14 days after enrollment)
|
Total sedation medication dose administered during endoscopy, calculated as midazolam equivalents in milligrams (mg).
Conversion formula: midazolam (mg) + propofol (mg)/20 + fentanyl (mcg)/100.
Lower doses indicate less sedation requirement.
|
During endoscopy procedure (assessed up to 14 days after enrollment)
|
|
Endoscopy Procedure Duration
Time Frame: Measured intraoperatively from endoscope insertion to withdrawal; endoscopy procedure occurs within 14 days of enrollment
|
Total procedure time in minutes, measured from endoscope insertion to withdrawal.
Shorter duration may indicate better patient tolerance and cooperation.
|
Measured intraoperatively from endoscope insertion to withdrawal; endoscopy procedure occurs within 14 days of enrollment
|
|
Incidence of Peri-procedural Adverse Events
Time Frame: From procedure start through 24 hours post-procedure (assessed up to 15 days after enrollment)
|
Number of participants experiencing adverse events during or within 24 hours post-procedure, graded by American Society for Gastrointestinal Endoscopy (ASGE) severity classification: mild (requires observation only), moderate (requires medical intervention), severe (requires hospitalization or ICU admission), or fatal.
Events include cardiopulmonary complications (hypoxia, hypotension, arrhythmia), perforation, bleeding, aspiration, or other complications.
|
From procedure start through 24 hours post-procedure (assessed up to 15 days after enrollment)
|
|
Hospital Length of Stay
Time Frame: From hospital admission to discharge (assessed up to 28 days)
|
Total hospital length of stay measured in days from admission to discharge.
Shorter length of stay indicates more efficient care and potentially fewer complications.
|
From hospital admission to discharge (assessed up to 28 days)
|
|
30-Day Unplanned Hospital Readmission Rate
Time Frame: From hospital discharge through 30 days post-discharge
|
Proportion of participants with unplanned hospital readmission related to the index endoscopy procedure or its complications within 30 days of hospital discharge.
Lower rates indicate better outcomes and care quality.
|
From hospital discharge through 30 days post-discharge
|
Collaborators and Investigators
Sponsor
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- LDYYczf2025110501
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Gastrointestinal Diseases
-
Medstar Health Research InstituteRecruitingGastrointestinal Cancer | Gastrointestinal Tumor | Gastrointestinal Surgery | Gastrointestinal Tumor SurgeryUnited States
-
Umeå UniversityCompletedFunctional Gastrointestinal DisorderSweden
-
The University of Texas Medical Branch, GalvestonCompletedGastrointestinal Disorders, Functional
-
Chang Gung Memorial HospitalNew Bellus EnterprisesUnknownNeoplasm | Functional Gastrointestinal DisorderTaiwan
-
Fondazione Don Carlo Gnocchi OnlusCatholic University of the Sacred Heart; University of PadovaRecruitingFunctional Gastrointestinal Disorders (FGIDs)Italy
-
Campus Bio-Medico UniversityRecruitingGastrointestinal Cancer | Gastrointestinal Hemorrhage | Gastrointestinal Lesions | Gastrointestinal Injury | Gastrointestinal Perforation | Gastrointestinal UlcerItaly
-
Massachusetts General HospitalEnrolling by invitationGastrointestinal Dysfunction | Gastrointestinal DiseaseUnited States
-
Jiangxi University of Traditional Chinese MedicineThe First Affiliated Hospital of Nanchang University; Second Affiliated Hospital... and other collaboratorsCompletedGastrointestinal DiseaseChina
-
Dr Anne PayneUniversity of LondonUnknownFunctional Gastrointestinal Disorders in ChildrenUnited Kingdom
-
Zealand University HospitalRecruiting
Clinical Trials on Enhanced Ward-Round Frequency With Standardized Communication
-
LanZhou UniversityNot yet recruitingColonoscopy | Bowel Preparation | Quality of HealthcareChina
-
University of Southern CaliforniaUniversity of PittsburghCompletedHypertensionUnited States
-
UNC Lineberger Comprehensive Cancer CenterNational Cancer Institute (NCI)Active, not recruiting
-
Yonsei UniversityRecruitingAdvanced CancerKorea, Republic of
-
SingHealth PolyclinicsAISG Health Grand ChallengeActive, not recruitingDiabetes Mellitus, Type 2Singapore
-
Soaad Tolba Mohammed Tolba BadawiCompletedTemporomandibular Disorders (TMDs)Egypt
-
Nova Scotia Health AuthorityActive, not recruitingPain, Postoperative | Opioid Use Disorder | Patient Satisfaction | Opioid Use | Orthognathic SurgeryCanada
-
Marmara UniversityUnknown
-
The University of Texas Health Science Center,...WithdrawnA Pilot Randomized Trial of a Comprehensive Transitional Care Program for Colorectal Cancer PatientsColorectal Cancer | Comprehensive Transitional Care ProgramUnited States